ECSP17012504A - Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones - Google Patents
Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camaronesInfo
- Publication number
- ECSP17012504A ECSP17012504A ECIEPI201712504A ECPI201712504A ECSP17012504A EC SP17012504 A ECSP17012504 A EC SP17012504A EC IEPI201712504 A ECIEPI201712504 A EC IEPI201712504A EC PI201712504 A ECPI201712504 A EC PI201712504A EC SP17012504 A ECSP17012504 A EC SP17012504A
- Authority
- EC
- Ecuador
- Prior art keywords
- clay
- product
- effects
- shrimp
- clostridium
- Prior art date
Links
- 230000000694 effects Effects 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 241000143060 Americamysis bahia Species 0.000 title 1
- 208000035143 Bacterial infection Diseases 0.000 title 1
- 208000022362 bacterial infectious disease Diseases 0.000 title 1
- 239000004927 clay Substances 0.000 abstract 4
- 241000193468 Clostridium perfringens Species 0.000 abstract 2
- 241000193163 Clostridioides difficile Species 0.000 abstract 1
- 241000193403 Clostridium Species 0.000 abstract 1
- 241000238557 Decapoda Species 0.000 abstract 1
- 241000287828 Gallus gallus Species 0.000 abstract 1
- 206010028851 Necrosis Diseases 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 241000607272 Vibrio parahaemolyticus Species 0.000 abstract 1
- 230000001154 acute effect Effects 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 235000013330 chicken meat Nutrition 0.000 abstract 1
- 208000021735 chronic enteritis Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Organic Chemistry (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Fodder In General (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Farming Of Fish And Shellfish (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Los Solicitantes han examinado dos especies de Clostridium, Clostridium difficile y Clostridium perfringens, y encontraron que las arcillas pueden adsorber la toxina producida por ambas y que un producto mezclado de arcilla puede disminuir los efectos de una afección prominente en pollos y conocida como Enteritis Crónica, que es causada por C. perfringens. Recientemente una arcilla o una mezcla de arcilla que puede ser una combinación de arcilla, levadura y una forma de un aminoácido funcional, se examinó y se encontró que ayuda a disminuir los efectos de la enfermedad de necrosis hepatopancreática aguda (AHPND) que también es conocida como Síndrome de Mortalidad Temprana (EMS) en camarones cuando se utilizó un modelo de estimulación que incluyó Vibrio parahaemolyticus.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462032238P | 2014-08-01 | 2014-08-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP17012504A true ECSP17012504A (es) | 2017-05-31 |
Family
ID=55218385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECIEPI201712504A ECSP17012504A (es) | 2014-08-01 | 2017-02-24 | Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones |
Country Status (4)
| Country | Link |
|---|---|
| CN (1) | CN107106597A (es) |
| EC (1) | ECSP17012504A (es) |
| MX (1) | MX2017001426A (es) |
| WO (1) | WO2016019343A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102295411B1 (ko) * | 2012-10-02 | 2021-08-27 | 오일-드리 코오포레이션 오브 아메리카 | 점토 제품 및 이의 용도 |
| EP3558509B1 (en) * | 2016-12-22 | 2022-03-02 | Firmenich SA | Microcapsules having a mineral layer |
| BR112020005255A2 (pt) * | 2017-09-19 | 2020-09-24 | Neopharma Japan Co., Ltd. | composição para decapoda com ácido 5-aminolevulínico |
| CN110547359B (zh) * | 2019-08-29 | 2022-07-26 | 清远海贝生物技术有限公司 | 一种虾用抗肠道弧菌保健料 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007011825A2 (en) * | 2005-07-19 | 2007-01-25 | Texas Enterosorbent, Inc. | Preservative and additive for food and feed |
| WO2010028215A1 (en) * | 2008-09-05 | 2010-03-11 | Mionix Corporation | Antimicrobial fish and shrimp feed |
| KR102295411B1 (ko) * | 2012-10-02 | 2021-08-27 | 오일-드리 코오포레이션 오브 아메리카 | 점토 제품 및 이의 용도 |
-
2015
- 2015-07-31 MX MX2017001426A patent/MX2017001426A/es unknown
- 2015-07-31 CN CN201580048525.5A patent/CN107106597A/zh active Pending
- 2015-07-31 WO PCT/US2015/043302 patent/WO2016019343A1/en active Application Filing
-
2017
- 2017-02-24 EC ECIEPI201712504A patent/ECSP17012504A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2017001426A (es) | 2017-08-02 |
| CN107106597A (zh) | 2017-08-29 |
| WO2016019343A1 (en) | 2016-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015022191A2 (pt) | compostos heteroarila, seu uso e composição que os compreende | |
| CL2015003731A1 (es) | Inhibidores de bromodominios | |
| BR112019001607A2 (pt) | inibidores macrocíclicos de quinases | |
| CL2015003117A1 (es) | Modificaciones en la estructura cristalina | |
| BR112017008659A2 (pt) | ?métodos e compostos de agonista de gip? | |
| ECSP17012504A (es) | Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones | |
| BR112015021888A8 (pt) | inibidores de dna-pk, seus usos e composição farmacêutica | |
| BR112015020389A2 (pt) | compostos carbazol úteis como inibidores de bromodomínio | |
| ES2838803T3 (es) | Método para reducir la producción total de gas y/o la producción de metano en un animal rumiante | |
| GT201400147A (es) | Pirimidinas y triazinas fusionadas sustituidas y su uso | |
| CL2015002677A1 (es) | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial. | |
| IN2015DN03322A (es) | ||
| NZ606589A (en) | 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof | |
| UY35693A (es) | Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso | |
| AR103077A1 (es) | Método para la producción de un sistema de administración farmacéutica | |
| BR112016029894A2 (pt) | método para aumentar o ganho de peso e/ou melhorar a razão de corversão de alimentos de animais de fazenda, e, uso de uma ou mais enzimas protolíticas em combinação com pelo menos uma fitase no alimento para animais. | |
| MX2015010003A (es) | Triterpenoides c-19 modificados, con actividad inhibidora de la maduracion del virus de inmunodeficiencia humana (vih). | |
| EA201692313A1 (ru) | Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ | |
| BR112017005660A2 (pt) | novos ativadores de guanilato ciclase solúvel e sua utilização | |
| CL2015002835A1 (es) | Nuevos derivados de piridina | |
| UA117032C2 (uk) | Селективний інгібітор фосфатидилінозитол-3-кінази-гамма | |
| WO2014106825A3 (en) | Methods and devices for identifying improper medical reporting | |
| DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
| EA201401117A1 (ru) | Композиции, содержащие пробиотики и комплекс пчелиной пыльцы/глины, способ их приготовления и их применение в питании и терапии | |
| AR099766A1 (es) | Inhibidores de la quinasa asociada al adaptador 1, composiciones que los comprenden y métodos para utilizarlos |